Meet the Team
HistoIndex Management Team
Dr Gideon HO, PhD
Co-founder & Chief Executive Officer (CEO)
An A*STAR National Science Scholar (Fellowship), Gideon has been involved in bio-imaging research, commercial development and corporate management. In 2010, Gideon co-founded HistoIndex as a spin-off from the Agency for Science, Technology and Research…
Dr Gideon HO
Co-founder & Chief Executive Officer (CEO)
An A*STAR National Science Scholar (Fellowship), Gideon has been involved in bio-imaging research, commercial development and corporate management. In 2010, Gideon co-founded HistoIndex as a spin-off from the Agency for Science, Technology and Research (A*STAR), to develop and commercialise the world’s first fully automated, quantitative, stain-free imaging system and gain a first-mover advantage in global healthcare markets. Under his direction as the CEO, the laser-based stain-free imaging system was successfully implemented in academic, clinical and pharmaceutical research in major universities, hospitals and contract reference facilities around the world.
Dr Dean TAI, PhD
Co-founder & Chief Scientific Officer (CSO)
As the CSO of HistoIndex, Dean is responsible for the strategic product development and worldwide research collaboration. Together with his HistoIndex co-founder, Dr. Gideon Ho, Dean has successfully launched the company’s platform technology in multiple global clinical studies…
Dr Dean TAI
Co-founder & Chief Scientific Officer (CSO)
As the CSO of HistoIndex, Dean is responsible for the strategic product development and worldwide research collaboration. Together with his HistoIndex co-founder, Dr. Gideon Ho, Dean has successfully launched the company’s platform technology in multiple global clinical studies. He has established multi-centre clinical trials with key opinion leaders, and successfully coordinated clinical validation worldwide using HistoIndex’s proprietary imaging and analysis technology .
Mr Paddy LIANG
Chief Operating Officer (COO)
Paddy oversees the strategic direction in the company’s global operations and leads the overall production and implemention of the platform technology. Since joining HistoIndex in 2013, Paddy has streamlined the manufacturing process, optimising the workflow…
Mr Paddy LIANG
Chief Operating Officer (COO)
Paddy oversees the strategic direction in the company’s global operations and leads the overall production and implementation of the platform technology. Since joining HistoIndex in 2013, Paddy has streamlined the manufacturing process, optimising the workflow across departments including Engineering, Supplier Management and Environment, Health and Safety (EHS).
Dr TENG Xiao, PhD
Chief Technology Officer (CTO)
Teng Xiao received his Ph.D. in Computer Engineering from Nanyang Technological University, Singapore. Since joining HistoIndex in 2013, Teng Xiao has designed and developed core image processing and machine learning (ML)…
Dr TENG Xiao
Chief Technology Officer (CTO)
Teng Xiao received his Ph.D. in Computer Engineering from Nanyang Technological University, Singapore. Since joining HistoIndex in 2013, Teng Xiao has designed and developed core image processing and machine learning (ML) algorithms for the company’s proprietary software technology.
Board of Directors
Mr David John JEANS, CBE
Non-Executive Chairman
John was appointed as Non-Executive Chairman in December 2022. His focus is to provide guidance to the senior management in transforming histopathological standards used in diagnostics and drug development with the global adoption of stain-free AI digital pathology for…
Mr David John JEANS, CBE
Non-Executive Chairman
John was appointed as Non-Executive Chairman in December 2022. His focus is to provide guidance to the senior management in transforming histopathological standards used in diagnostics and drug development with the global adoption of stain-free AI digital pathology for fibrotic diseases and oncology.
John has helmed senior leadership positions in international healthcare corporations such as BMS and J&J. He was previously the Chairman of Cardiff University, Deputy Chief Executive of the UK Medical Research Council, chaired the Trustee Board of MRC Technology, and served as Trustee of the Francis Crick Institute. He is currently the Chairman of the Digital Health & Care Innovation Centre in Scotland and in Singapore, John is a co-Chair of the Strategic Advisory Panel at the DxD Hub, which is part of the Agency for Science, Technology and Research (A*STAR). In 2012, John was awarded the Commander of the Order of the British Empire (CBE) for his significant contributions to Life Sciences, Healthcare and Science.
Mr SIM Kok Hwee
Non-Executive Director
Kok Hwee is an experienced corporate and operations leader with the Zicom Group, having assumed various responsibilities. His corporate responsibilities include banking relationships, treasury management, mergers and…
Mr SIM Kok Hwee
Non-Executive Director
Kok Hwee is an experienced corporate and operations leader with the Zicom Group, having assumed various responsibilities. His corporate responsibilities include banking relationships, treasury management, mergers and acquisitions, strategic partnerships and fund raising. Operationally, he has led group wide implementations of the ISO Quality Management Systems and also Enterprise Resource Planning Systems to optimize business performance.
As the Chief Executive Officer of ZIG Ventures Pte. Ltd. (formerly known as Zicom MedTacc), his focus is to co-invest with SPRING into promising early stage medtech companies. Apart from leveraging on the precision engineering and manufacturing infrastructure of the group, Kok Hwee leads a team of healthcare commercialization professionals to proactively build capabilities within the portfolio companies and to forge strategic partnerships with the global
healthcare ecosystem.
Kok Hwee has a Masters of Science Degree in Financial Engineering from Columbia University, New York, USA and a Bachelor of Science Degree in Industrial and Operations Research from the University of Michigan, Ann Arbor, USA (Magna Cum Laude).
Other Appointments: Executive Director, Zicom Group; Chief Executive Officer, ZIG Ventures Pte. Ltd.
Mr SIM Giok Lak
Non-Executive Director
Giok Lak founded Zicom Group in 1978 and is its Group Chairman and Managing Director. He is an experienced entrepreneur and knowledgeable business executive with expertise in public accounting, corporate development…
Mr SIM Giok Lak
Non-Executive Director
Giok Lak founded Zicom Group in 1978 and is its Group Chairman and Managing Director. He is an experienced entrepreneur and knowledgeable business executive with expertise in public accounting, corporate development, financial and industrial management and international trade.
Giok Lak has been appointed as a Board member to SPRING, and chairs the Grant Appeal Panel and Growth Enterprise Panel. He is also a strategic advisor to the DxD Hub, which is part of the Agency for Science, Technology and Research (A*STAR) and Singapore National Eye Center Incubation Board. Additionally, he is also on the Board of Governors, UOB-SMU Asian Enterprise. In 2008, he was the recipient of the Ernest & Young Entrepreneur of the Year (Industrial Products) award in Singapore.
Giok Lak qualified as an accountant in 1967. He is Fellow of the Australian Society of Certified Practising Accountants and Fellow of the Institute of Certified Public Accountants, Singapore.
Other Appointments: Chairman, Zicom Group
Dr Gideon HO, PhD
Executive Director
An A*STAR National Science Scholar (Fellowship), Gideon has been involved in bio-imaging research, commercial development and corporate management. In 2010, Gideon co-founded HistoIndex as a spin-off from the Agency for Science, Technology and Research….
Dr Gideon HO
Co-founder & Chief Executive Officer (CEO)
An A*STAR National Science Scholar (Fellowship), Gideon has been involved in bio-imaging research, commercial development and corporate management. In 2010, Gideon co-founded HistoIndex as a spin-off from the Agency for Science, Technology and Research (A*STAR), to develop and commercialise the world’s first fully automated, quantitative, stain-free imaging system and gain a first-mover advantage in global healthcare markets. Under his direction as the CEO, the laser-based stain-free imaging system was successfully implemented in academic, clinical and pharmaceutical research in major universities, hospitals and contract reference facilities around the world.
Dr Dean TAI, PhD
Executive Director
As the CSO of HistoIndex, Dean is responsible for the strategic product development and worldwide research collaboration. Together with his HistoIndex co-founder, Dr. Gideon Ho, Dean has successfully launched the company’s platform technology in multiple global clinical studies…
Dr Dean TAI
Co-founder & Chief Scientific Officer (CSO)
As the CSO of HistoIndex, Dean is responsible for the strategic product development and worldwide research collaboration. Together with his HistoIndex co-founder, Dr. Gideon Ho, Dean has successfully launched the company’s platform technology in multiple global clinical studies. He has established multi-centre clinical trials with key opinion leaders, and successfully coordinated clinical validation worldwide using HistoIndex’s proprietary imaging and analysis technology .
HistoIndex Scientific Advisory Board
Professor Stephen Harrison, MD, FACP, FAASLD, COL(ret.)
Other Positions:
Medical Director, Pinnacle Clinical Research, San Antonio, Texas, USA
Visiting Professor of Hepatology, Radcliffe Department of Medicine, University of Oxford, UK
Professor Quentin Anstee, MBBS, PhD, MRCP(UK), FRCP
Other Positions:
Professor of Experimental Hepatology; Consultant Hepatologist, Institute of Cellular Medicine,
Newcastle University, UK
Honorary Consultant Hepatologist, Liver Unit, Freeman Hospital, Newcastle, UK
Professor Arun Sanyal, MD
Other Positions:
Professor, Department of Internal Medicine, Division of Gastroenterology, Hepatology and Nutrition,
Virginia Commonwealth University, Virginia, USA
President, Chair and Chief Medical Officer, Sanyal Biotechnology
Professor Wei Lai, MD, PhD
Other Position:
Vice President of Tsinghua Chang Gung Hospital, Beijing, China
Professor Jacob George, MBBS, FRACP, PhD, FAASLD
Other Positions:
Robert W Storr Chair of Hepatic Medicine,
Professor of Gastroenterology and Hepatic Medicine,
Faculty of Medicine, University of Sydney, Australia
Director, Storr Liver Centre, The Westmead Institute for Medical Research;
Head, Department of Gastroenterology & Hepatology, Westmead Hospital and Sydney West Local Health District – Obesity-related Liver Disease and Cancer Group
HistoIndex Strategic Advisors
Professor Nikolai V Naoumov, MD, PhD, FRCP, FRCPath, FAASLD, FaoP
Advisor
Independent Expert in Digital Pathology, Drug Development and Research in Liver Diseases
London, United Kingdom